Sotera Health Co
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.2B | $1.1B | $1.0B | $1.0B | $931.5M |
| Cost of revenue | $518.1M | $498.1M | $472.1M | $446.7M | $412.8M |
| Gross profit | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M |
| Selling, general & administrative | $252.8M | $242.6M | $236.7M | $245.7M | $198.2M |
| Operating expenses | — | $304.7M | $300.5M | $308.7M | $261.9M |
| Operating income | — | $297.6M | $276.7M | $248.3M | $256.7M |
| Pretax income | $147.5M | $113.9M | $106.0M | -$243.1M | $175.7M |
| Income tax expense | $69.6M | $69.5M | $54.7M | -$9.5M | $58.6M |
| Net income | $77.9M | $44.4M | $51.4M | -$233.6M | $116.9M |
| Balance Sheet | |||||
| Cash and equivalents | $344.6M | $277.2M | $296.4M | $395.2M | $106.9M |
| Current assets | $613.4M | $526.0M | $557.2M | $645.0M | $346.0M |
| Total assets | $3.3B | $3.1B | $3.1B | $3.1B | $2.8B |
| Current liabilities | $249.6M | $191.0M | $230.7M | $791.6M | $161.2M |
| Total liabilities | $2.7B | $2.7B | $2.7B | $2.8B | $2.2B |
| Total debt | $2.2B | $2.3B | $2.3B | $2.0B | $1.8B |
| Stockholders' equity | $606.0M | $404.9M | $443.7M | $350.2M | $586.1M |
| Cash Flow Statement | |||||
| Cash from operations | $287.2M | $224.2M | -$147.7M | $278.0M | $281.5M |
| Depreciation and amortization | $94.9M | $84.3M | $76.6M | $64.3M | $64.2M |
| Stock-based compensation | $30.9M | $36.8M | $32.2M | $21.2M | $13.9M |
| Capital expenditure | $138.0M | $179.1M | $215.0M | $182.4M | $102.2M |
| Free cash flow | $149.2M | $45.1M | -$362.7M | $95.6M | $179.4M |
| Dividends paid | — | — | — | — | $0 |
| Share repurchases | — | — | — | $0 | $0 |
| Impairments | — | — | — | — | $0 |
Shares outstanding 285.2M · Free float 84.6%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.